Abstract: The method for treating wastewater includes a first flocculation-and-sedimentation process and a second flocculation-and-sedimentation process, wherein the first flocculation-and-sedimentation process include: passing wastewater through a first flocculation reaction tank; passing the first treated water through a third flocculation reaction tank; passing the third treated water through a fourth flocculation reaction tank; and passing the fourth treated water through a first sedimentation tank to generate fifth treated water and sludge, and the second flocculation-and-sedimentation process include: passing the fifth treated water through a fifth flocculation reaction tank to generate sixth treated water; passing the sixth treated water through a sixth flocculation reaction tank to generate sixth treated water; passing the sixth treated water through a seventh flocculation reaction tank to generate eighth treated water; and passing the eighth treated water through a second sedimentation tank to generate ninth t

Abstract: A charging control device mounted inside an electric vehicle, the charging control device including a communication channel configured to be connected with an EVSE (electric vehicle supply equipment), a controller configured to be connected with the communication channel, and an internal power protection unit connected with a battery of the electric vehicle, wherein the communication channel is based on a protocol of supporting a power line communication (PLC) or a controller area network (CAN), wherein the controller includes a task unit, the task unit operating based on a charging mode of a charging standard.

Abstract: The present invention provides a recombinant expression vector comprising a gene encoding canine parvovirus 2a VP2 or 2b VP2 protein, a recombinant plant into which the vector is transformed, a vaccine composition against canine parvovirus, comprising canine parvovirus 2a VP2 or 2b VP2 protein obtained from the recombinant plant, and a composition for diagnosing canine parvovirus. When the recombinant plant of the present invention is used, canine parvovirus 2a VP2 or 2b VP2 antigen protein can be rapidly produced with high efficiency. Since the composition for diagnosing canine parvovirus according to the present invention uses a recombinant antigen protein, there is no possibility of contamination due to live virus handling, and thus the composition is safe, and the presence or absence of canine parvovirus infection can be rapidly diagnosed from a large amount of samples.

Abstract: The present invention provides a recombinant expression vector comprising a gene encoding canine parvovirus 2a VP2 or 2b VP2 protein, a recombinant plant into which the vector is transformed, a vaccine composition against canine parvovirus, comprising canine parvovirus 2a VP2 or 2b VP2 protein obtained from the recombinant plant, and a composition for diagnosing canine parvovirus. When the recombinant plant of the present invention is used, canine parvovirus 2a VP2 or 2b VP2 antigen protein can be rapidly produced with high efficiency. Since the composition for diagnosing canine parvovirus according to the present invention uses a recombinant antigen protein, there is no possibility of contamination due to live virus handling, and thus the composition is safe, and the presence or absence of canine parvovirus infection can be rapidly diagnosed from a large amount of samples.

Abstract: The present invention relates to: a rabies virus glycoprotein comprising an amino acid sequence represented by SEQ ID NO: 2; a recombinant vector for producing the glycoprotein; a transformant comprising the vector; and a vaccine composition comprising the rabies glycoprotein, and the like.